Login / Signup

Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study.

Melinda JiangLydia LamJoshua G KovoorJames KimberAashray K GuptaBrandon StrettonRudy GohStephen Bacchi
Published in: Transfusion medicine (Oxford, England) (2023)
Alterations to IVIg treatment due to AR are commonly required in neurology patients, and may be associated with higher daily doses of IVIg.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • physical activity
  • emergency department
  • combination therapy
  • adverse drug